JP2001161314A - Motor ability enhancer based on ferulic acid salt - Google Patents
Motor ability enhancer based on ferulic acid saltInfo
- Publication number
- JP2001161314A JP2001161314A JP37646199A JP37646199A JP2001161314A JP 2001161314 A JP2001161314 A JP 2001161314A JP 37646199 A JP37646199 A JP 37646199A JP 37646199 A JP37646199 A JP 37646199A JP 2001161314 A JP2001161314 A JP 2001161314A
- Authority
- JP
- Japan
- Prior art keywords
- sportsmen
- motor ability
- acid salt
- ferulic acid
- enhancer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
【0001】[0001]
【発明の属する技術分野】本発明は、医療分野で神経障
害患者に対して投与されており、米胚芽・種子膜抽出物
からなるγ−オリザノールの主成分であるフェルラ酸塩
とオクタコサノールの組合せによる中枢性疲労と筋肉疲
労の阻止及び筋持久力向上と筋−神経系運動能力を最大
限に発揮させることが目的である。TECHNICAL FIELD The present invention relates to a pharmaceutical composition which is administered to a patient suffering from a neurological disorder in the medical field, and comprises a combination of ferulate and octacosanol, which are the main components of γ-oryzanol composed of rice germ / seed membrane extract. The purpose is to prevent central fatigue and muscle fatigue, improve muscle endurance, and maximize muscle-nervous system motor skills.
【0002】[0002]
【従来の技術】フェルラ酸塩を主成分とするγ−オリザ
ノールは、自律神経系の中枢である視床下部、大脳辺縁
系を賦活するために、自律神経失調、内分泌平衡障害、
精神神経変調に基づく諸症状の改善、微少循環血流促進
作用、抗酸化性、成長促進作用、性腺刺激作用、ビタミ
ンE様作用を目的とする治療薬剤として利用されてい
る。消化の過程で殆どがフェルラ酸塩に変換されるγ−
オリザノールは、殆ど水に溶解しない点で製剤化の欠点
とされ、加温下で溶解するが冷却によってその後経時的
に沈殿することがあり、製品化にあたって溶解性、分散
性等の点で制約されるため、医薬品としての利用が中心
であった。2. Description of the Related Art Gamma-oryzanol, which is mainly composed of ferulate, activates the hypothalamus and the limbic system which are the centers of the autonomic nervous system.
It has been used as a therapeutic drug for improving various symptoms based on neuropsychiatric modulation, promoting microcirculatory blood flow, antioxidant properties, promoting growth, gonad stimulating action, and vitamin E-like action. Γ-, which is mostly converted to ferulate during the digestion process
Oryzanol is considered to be a drawback of formulation because it hardly dissolves in water.It dissolves under heating, but may precipitate over time after cooling, and is limited in terms of solubility, dispersibility, etc. in commercialization. Therefore, it was mainly used as pharmaceuticals.
【0003】[0003]
【発明が解決しようとする課題】γ−オリザノールと同
じ米胚芽・種子膜から抽出したオクタコサノールは、4
0年前に米国イリノイ大学フィジカルフィットネス研究
所のT.K.Curetonらによってオクタコサノー
ルの機能が報告されている。その規模は対象人数894
人、期間20年の長きにわたった。また、その内容も4
2項目を対象としたトレーニングプログラムによって評
価されている。研究内容を要約すると、耐久力・精力・
体力の増強、反射・鋭敏性の向上、ストレスの抵抗性の
向上、性ホルモンの刺激・筋肉痙攣の低減、心筋を含む
筋肉機能の良化、収縮期血圧の低下、基礎代謝の向上な
どである。1956年にEzra Levin(イリノ
イ大学)らによってオクタコサノールを用いた「スタミ
ナ増強剤」等の特許が提出されている。その後、オクタ
コサノールの機能についての報告はほとんどない。19
84年〜1989年の間に2〜3の実験例が出ている程
度である。また、オクタコサノールを利用した加工食品
も、現在に至まで数品目しか上市されていない。その要
因としてはオクタコサノールが高融点のため、水にはほ
とんど溶解せず、多くの食品に利用することが困難だっ
た点にある。この様々な生理・薬理作用を利用してオク
タコサノールとγ−オリザノールの主成分であるフェル
ラ酸塩を組合せ、運動能力増強剤の製品化を実現するこ
とにある。Octacosanol, extracted from the same rice germ / seed membrane as γ-oryzanol, is 4%.
0 years ago, T.A. of the University of Illinois Physical Fitness Laboratory. K. The function of octacosanol has been reported by Cureton et al. The scale is 894 people.
People have been around for 20 years. The contents are also 4
It is evaluated by a training program targeting two items. To summarize the research content, endurance, energy,
Increasing physical strength, improving reflex / sensitivity, improving stress resistance, stimulating sex hormones / reducing muscle spasm, improving muscle function including myocardium, lowering systolic blood pressure, improving basal metabolism, etc. . In 1956, Ezra Levin (University of Illinois) et al. Filed a patent for "stamina enhancer" using octacosanol. Since then, there have been few reports on the function of octacosanol. 19
Between 1984 and 1989, only a few experimental examples appeared. In addition, only a few processed foods using octacosanol have been put on the market to date. The reason is that octacosanol has a high melting point, so that it hardly dissolves in water, making it difficult to use in many foods. It is an object of the present invention to commercialize an athletic ability enhancer by combining octacosanol and ferulate, which is a main component of γ-oryzanol, by utilizing various physiological and pharmacological actions.
【0004】[0004]
【課題を解決するための手段】フェルラ酸塩は、ほとん
どすべての植物に一般に含まれているフェノール酸であ
る。実験試料としては、米胚芽・種子膜に含まれている
ステロール類のフェルラ酸塩エステルであるγ−オリザ
ノールが使用される。γ−オリザノールは、消化の過程
でほとんどがフェルラ酸に変換される。文献:Powe
rs,S.,Byrd,R.,Tulley,R.,a
nd Callender,T.,Effects o
f caffeine ingestion on m
etabolism and performance
during gradedexercise,Eu
r.J.Appl Physiol.,40,301,
1983。フェルラ酸は、ノルメタネフリンの構造によ
く類似している、ノルエピネフリンの最初の代謝産物で
ある。文献:Bruni,O.j.,GammaOry
zanol−The Facts,Claudell
Publishing,Houston,TX,198
9。フェルラ酸塩の投与は、脳下垂体でソマトトロピン
合成を促進するような、視床下部のノルエピネフリンを
増加させる効果と類似した結果を引き起こした。文献:
Ishihama,A.,Hamatsu,Y.,an
d Ito,T.,On the effects o
f gamma oryzanol upon ant
erior lobe rat pituitary,
Yokohama Med.Bull.,17(5),
183,1966.Yamauchi,J.,Taka
hashi,J.,Uneki,T.,Yakushi
ji,W.,Nakashima,Y.,Miyosh
i,M.,and Ofuji,T.,The eff
ects of gamma oryzanolonr
at pituitary hormone secr
etion.FoliaEndocrinol.Jp
n.,56(8),1130,1980.Ieiri,
T.,Kase,N.,Hashigami,Y.,K
obori,H.,Nakamura,T.,and
Shimoda,S.,The effects of
gamma oryzanol on the hy
pothalamo−pituitary axis
in the rat,Folia Endocrin
ol.Jpn.,58(10),1350,1982.
Bruni,O.J.,Gamma Oryzanol
−The Facts,Claudell Publi
shing,Houston,TX,1989.100
mgまたは500mgのフェルラ酸塩(0.3mg/k
g)を若い雌牛に注入した結果、血清ソマトトロピン値
が有意に増加した。文献:Gorewit,R.C.,
Pituitary and thyroid hor
moneresponses of heifers
after ferulicacid adminis
tration,J.Diary Sci.,66,6
24,1983.他の脳下垂体ホルモンは影響を受けな
かった。さらに、フェルラ酸塩は、invitro及び
in vivoの双方の検討でビタミンEに似た活性を
示したことから、40名の女性に300mgのγ−オリ
ザノールを4〜8週間にわたり経口摂取した結果、高い
値であった血清過酸化脂質レベルが有意に減少し、正常
レベルに戻った。それ故、フェルラ酸塩が抗酸化物質で
あることを確認した。文献:Yagi K.and O
hishi,N.,Action of feruli
c acid and its derivative
s as antioxidants,J.Nutr.
Sci.Vitaminol.,25,127,197
9.Tajima,K.,Sakamoto,M.,O
kada,K.,Mukai,K.,Ishizu,
K.,Mori,H.,and Sakurai,
H.,Reaction of biological
phenolic antioxidants wi
th superoxide generated b
y cytochrome P450 model s
ystem,Biology.Biophys.Re
s.Commun.,115(3),1002,198
3.Bors,W.,Michel,C.,Erben
Russ,M.,Kreileder,B.,Tai
t,D.,and Saran,M.,Rate co
nstants of sparingly wate
r−soluble pheolic antioxi
dants with hydroxyl radic
als,in Oxygen Radicals in
Chemistry and Biology,Bo
rs,W.,Saran,M.,and Tait,
D.,Eds.,Walter deGruyter,
Berlin,1984,95.Yin,Z.Z.,W
ang,J.P.,and Xu,L.N.,Effe
ct of sodium Ferulate on
malondialdehyde productio
n fromthe platelets of ra
ts,Acta Pharmacol.Sin.,7
(4),336,1986.Ohta,S,Furuk
awa,M.,and sHINODA,M.,Che
mical protectors against
radiaction.23.Radioprotec
tive activities of feruli
c acidand its related com
pounds,YakugakuZasshi,104
(7),793,1984.Ishida,M.,Ef
fects of gamma oryzanolon
serm lipid peroxide leve
l and clinicalsymptoms of
patients with climacteri
c disturbances,Asia−Ocean
ia J.Obset.Gynaecol.,10
(3),317,1984.ソマトトロピンに影響を及
ぼし、抗酸化作用が期待できることから、トレーニング
を積んだウエイトリフティング競技者を対象に、8週間
にわたり毎日フェルラ酸塩を経口摂取して運動能力増強
作用について検討した。その結果、除脂肪体重の有意な
増加、体脂肪の有意な減少、筋力の有意な増加、運動回
復能力の改善、運動後の筋肉痛の減少が確認された。ま
た、激しい運動後、エンドルフィンが極めて有意に増大
していたことから、動物実験で示唆されたカテコールア
ミン神経伝達物質に及ぼす視床下部作用を支持すること
ができる。それ故、フェルラ酸塩の補給は複数のレジス
タンストレーニング効果を向上させる。文献:Bucc
i,L.R.,A natural magic bu
llet.Flex,April,25,1989.B
ucci,L.R.,Blackman,G.,Def
ord,W.,Kaufmann,R.,Mandel
−Tayes,C.,Sparks,W.S.,J.
C.,and Hickson,J.F.Effect
of ferulate on strength
and body composition of w
eightlifers,J.Appl.SportS
ci.Res.4(3),104,1990. Bon
ner,B.,Warren,B.,and Bucc
i,L.,Influenceof ferulate
supplementation on postex
ercise stress hormore lev
els afterrepeats exercise
stress,J.Appl.SportSci.R
es.,4(3),110,1990.一般的な植物成
分であり、単なる栄養成分であるフェルラ酸塩に、疲労
知覚の抑制作用を有するエンドルフィンと脳下垂体のソ
マトトロピンに影響が見られたこと及び抗酸化物質であ
ることを確認し、運動能力増強作用を見いだした。SUMMARY OF THE INVENTION Ferulates are phenolic acids commonly found in almost all plants. As the experimental sample, γ-oryzanol, which is a ferulate ester of sterols contained in rice germ / seed membrane, is used. γ-Oryzanol is mostly converted to ferulic acid during the digestion process. Literature: Powe
rs, S.R. , Byrd, R .; Tulley, R .; , A
nd Callender, T.W. , Effects o
f caffineine ingestion on m
etabolism and performance
During graded exercise, Eu
r. J. Appl Physiol. , 40, 301,
1983. Ferulic acid is the first metabolite of norepinephrine, which closely resembles the structure of nometanephrine. Literature: Bruni, O .; j. , GammaOry
zanol-The Facts, Claudell
Publishing, Houston, TX, 198
9. Administration of ferulate caused similar effects as increasing hypothalamic norepinephrine, such as promoting somatotropin synthesis in the pituitary gland. Literature:
Ishihama, A .; , Hamatsu, Y .; , An
d Ito, T .; , On the effects o
f gamma oryzanol up ant
erior love rat pituitary,
Yokohama Med. Bull. , 17 (5),
183, 1966. Yamauchi, J .; , Taka
hashi, J .; Uneki, T .; , Yakushi
ji, W .; , Nakashima, Y .; , Miyoshi
i, M. , And Ofuji, T .; , The eff
ects of gamma oryzanolonr
at pituitary hormone secr
etion. FoliaEndocrinol. Jp
n. , 56 (8), 1130, 1980. Ieiri,
T. Kase, N .; , Hashigami, Y .; , K
obori, H .; , Nakamura, T .; , And
Shimoda, S .; , The effects of
gamma oryzanol on the hy
pothalamo-pituitary axis
in the rat, Folia Endocrin
ol. Jpn. , 58 (10), 1350, 1982.
Bruni, O .; J. , Gamma Oryzanol
-The Facts, Claudell Public
shing, Houston, TX, 1989.100.
mg or 500 mg of ferulate (0.3 mg / k
Injection of g) into young cows resulted in a significant increase in serum somatotropin levels. Reference: Gorewit, R .; C. ,
Pituitary and thyroid hor
monesponses of heifers
after ferulicacid admins
transition, J.A. Diary Sci. , 66,6
24, 1983. Other pituitary hormones were not affected. In addition, ferulate showed an activity similar to vitamin E in both in vitro and in vivo studies, and as a result of ingesting 300 mg of γ-oryzanol orally for 40 to 4 women for 4 to 8 weeks. Serum lipid peroxide levels were significantly reduced and returned to normal levels. Therefore, it was confirmed that ferulate was an antioxidant. Literature: Yagi K. and O
hishi, N .; , Action of feruli
c acid and it's derivatives
s as antioxidants, J. et al. Nutr.
Sci. Vitaminol. , 25, 127, 197
9. Tajima, K .; , Sakamoto, M .; , O
kada, K .; Mukai, K .; , Ishizu,
K. , Mori, H .; , And Sakurai,
H. , Reaction of biological
phenolic antioxidants wi
the superoxide generated b
y cytochrome P450 model s
ystem, Biology. Biophys. Re
s. Commun. , 115 (3), 1002, 198
3. Bors, W.C. Michael, C .; , Erben
Russ, M .; Kreilder, B .; , Tai
t, D. , And Saran, M .; , Rate co
nstants of sparingly water
r-soluble pheolic antioxi
dants with hydroxyradical
als, in Oxygen Radicals in
Chemistry and Biology, Bo
rs, W.S. , Saran, M .; , And Tait,
D. , Eds. , Walter deGruyter,
Berlin, 1984, 95. Yin, Z .; Z. , W
ang, J .; P. , And Xu, L .; N. , Effe
ct of sodium ferulate on
malondialdehyde productio
n from the platesets of ra
ts, Acta Pharmacol. Sin. , 7
(4), 336, 1986. Ohta, S, Furuk
awa, M .; , And SHINODA, M .; , Che
medical protectors against
radiation. 23. Radioprotec
active activities of feruli
c acidand it's related com
pounds, YakugakuZasshi, 104
(7), 793, 1984. Ishida, M .; , Ef
facts of gamma oryzanolon
serm lipid peroxide level
l and clinical symptoms ofs
patents with climacteri
c disturbances, Asia-Ocean
ia J.J. Obset. Gynaecol. , 10
(3), 317, 1984. Since it affects somatotropin and can be expected to have an antioxidant effect, a weight-lifting athlete who has been trained was examined for a motor-enhancing effect by orally ingesting ferulate every day for 8 weeks. As a result, a significant increase in lean body mass, a significant decrease in body fat, a significant increase in muscle strength, an improvement in exercise recovery ability, and a decrease in muscle pain after exercise were confirmed. In addition, endorphins were significantly increased after strenuous exercise, supporting the hypothalamic effect on catecholamine neurotransmitters suggested in animal studies. Therefore, supplementation with ferulate improves multiple resistance training effects. Reference: Bucc
i, L. R. , A natural magic bu
llet. Flex, April, 25, 1989. B
ucci, L .; R. , Blackman, G .; , Def
ord, W.C. Kaufmann, R .; , Mandel
-Tayes, C.I. , Sparks, W.C. S. , J. et al.
C. , And Hickson, J. et al. F. Effect
of ferulate on strength
and body composition of w
Eightlighters, J. et al. Appl. SportS
ci. Res. 4 (3), 104, 1990. Bon
ner, B .; , Warren, B .; , And Bucc
i, L. , Influenceof ferulate
supplementation on postex
ercise stress hormore lev
els afterrepeats exercise
stress, J.M. Appl. SportSci. R
es. , 4 (3), 110, 1990. It is a general plant ingredient and ferulate, which is just a nutrient ingredient, confirmed that endorphin, which has an inhibitory effect on fatigue perception, and somatotropin of the pituitary gland were confirmed to be antioxidants, We found the ability to enhance athletic ability.
【0005】[0005]
【発明の実施の形態】フェルラ酸塩は、米の胚芽・種子
膜から抽出された素材で、できるだけ天然、自然な状態
に維持し、かつその新鮮さを保持でき、素材から製品化
への加工工程において、添加物や熱・水・圧力・空気酸
化等の品質劣化要因の少ない商品形態に考慮しなければ
ならない。また、1日摂取量、体内吸収、食べやすさ、
取り扱いやすさ、コスト、関係法規等の要因も考慮しな
ければならない。フェルラ酸塩による製品は、自体公知
の食品或は食品成分、賦形剤、医薬担体と自体公知の方
法で合して、運動能力増強を目的とする加工食品とする
ことができる。γ−オリザノールの主成分であるフェル
ラ酸塩及び同じ米の胚芽・種子膜から抽出されたオクタ
コサノールを用いる食品成分或は食品は特に限定するも
のではなく、目的とする具体的用途に応じて当業者が適
宜選択できる。また、形態も特に限定するものではな
く、具体的用途に応じて、種々の個体や形状にすること
ができる。BEST MODE FOR CARRYING OUT THE INVENTION Ferulate is a material extracted from rice germ / seed membrane, which can be maintained as natural and natural as possible and can maintain its freshness. In the process, it is necessary to consider a product form in which additives and quality deterioration factors such as heat, water, pressure, and air oxidation are small. In addition, daily intake, body absorption, ease of eating,
Factors such as ease of handling, cost, and related laws and regulations must also be considered. The ferulate-based product can be combined with a known food or a food ingredient, an excipient, or a pharmaceutical carrier by a known method to obtain a processed food aimed at enhancing exercise performance. Food ingredients or foods using ferulate, which is the main component of γ-oryzanol, and octacosanol extracted from the same rice germ / seed membrane are not particularly limited, and those skilled in the art may use the food ingredients or foods according to the specific intended use. Can be appropriately selected. Also, the form is not particularly limited, and various forms and shapes can be used according to specific applications.
【0006】[0006]
【実施例】トレヘニングを積んだ男性長距離ランナー6
名を対象に50mg/日のフェルラ酸塩を3週間与えた
結果、コルチゾール、テストステロン、エンドルフィン
は安静時と比較して有意に増加した。とくに、エンドル
フィンは有意に増加した。ウエイトリフティング競技者
に8週間以上フェルラ酸塩を経口摂取させた結果、レッ
グプレス、チェストプレスについて1回最大出力が増加
した。[Example] Male long-distance runner 6 with trehenning
As a result of giving 50 mg / day of ferulate for 3 weeks to the subjects, cortisol, testosterone, and endorphin significantly increased as compared with those at rest. In particular, endorphin increased significantly. Oral ingestion of ferulate by weightlifting athletes for more than 8 weeks resulted in one increase in maximum output for leg press and chest press.
【0007】一般学生16名に1000μg/日のオク
タコサノールを8週間与えた結果、視覚刺激に対する反
応時間と握力が有意に増加した。[0007] As a result of giving octacosanol of 1000 µg / day to 16 general students for 8 weeks, the reaction time to the visual stimulus and the grip strength significantly increased.
【0008】[0008]
【発明の効果】消化の過程でフェルラ酸塩に変換される
γ−オリザノールは、生理作用、臨床応用効果について
数多くの報告がみられ、医薬品としてすでに利用されて
いる。オクタコサノールにおいても、Cureton博
士はオクタコサノールの機能を「筋肉及び人体のエネル
ギー生成に触媒的に多様な作用をしている。」と結論付
けている。以上のことから米胚芽・種子膜の抽出物であ
るフェルラ酸塩は、運動能力増強効果が充分に期待でき
る。As described above, γ-oryzanol, which is converted into ferulate during the digestion process, has been reported many times for its physiological action and clinical application effect, and has already been used as a drug. In octacosanol, Dr. Cureton concludes that octacosanol's function is "catalytically diverse in the energy production of muscle and human body." From the above, ferulate, which is an extract of rice germ / seed membrane, can be expected to have a sufficient exercise ability enhancing effect.
Claims (1)
るフェルラ酸塩を主原料とする加工食品の運動能力増強
剤。1. An agent for enhancing athletic performance of a processed food, which is mainly composed of ferulate having a structure similar to that of normetanephrine.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP37646199A JP2001161314A (en) | 1999-12-10 | 1999-12-10 | Motor ability enhancer based on ferulic acid salt |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP37646199A JP2001161314A (en) | 1999-12-10 | 1999-12-10 | Motor ability enhancer based on ferulic acid salt |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2001161314A true JP2001161314A (en) | 2001-06-19 |
Family
ID=18507175
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP37646199A Pending JP2001161314A (en) | 1999-12-10 | 1999-12-10 | Motor ability enhancer based on ferulic acid salt |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2001161314A (en) |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT412381B (en) * | 2003-12-04 | 2005-02-25 | Wolfgang Peer | Combined nutritional supplement, useful particularly for increasing sporting performance, contains mixture of inorganic salts, amino acids, vitamins and carbohydrates, also creatine, inositol and tocopherol |
JP2005272355A (en) * | 2004-03-25 | 2005-10-06 | Tsuno Rice Fine Chemicals Co Ltd | Agent for ameliorating cerebral function |
WO2006092992A1 (en) * | 2005-02-28 | 2006-09-08 | Kao Corporation | Prophylactic antistress agent |
WO2012090676A1 (en) * | 2010-12-26 | 2012-07-05 | Sakai Kazuo | Novel medicinal composition and utilization of same |
JP2017193497A (en) * | 2016-04-19 | 2017-10-26 | オリザ油化株式会社 | Muscle-enhancing agent |
JP7126731B1 (en) | 2021-10-19 | 2022-08-29 | 丸善製薬株式会社 | AMPK activator, motor function improver, muscle endurance improver and muscle atrophy inhibitor |
-
1999
- 1999-12-10 JP JP37646199A patent/JP2001161314A/en active Pending
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AT412381B (en) * | 2003-12-04 | 2005-02-25 | Wolfgang Peer | Combined nutritional supplement, useful particularly for increasing sporting performance, contains mixture of inorganic salts, amino acids, vitamins and carbohydrates, also creatine, inositol and tocopherol |
JP2005272355A (en) * | 2004-03-25 | 2005-10-06 | Tsuno Rice Fine Chemicals Co Ltd | Agent for ameliorating cerebral function |
WO2006092992A1 (en) * | 2005-02-28 | 2006-09-08 | Kao Corporation | Prophylactic antistress agent |
WO2012090676A1 (en) * | 2010-12-26 | 2012-07-05 | Sakai Kazuo | Novel medicinal composition and utilization of same |
JP5807018B2 (en) * | 2010-12-26 | 2015-11-10 | 和夫 酒井 | Novel pharmaceutical composition and use thereof |
JP2017193497A (en) * | 2016-04-19 | 2017-10-26 | オリザ油化株式会社 | Muscle-enhancing agent |
JP7126731B1 (en) | 2021-10-19 | 2022-08-29 | 丸善製薬株式会社 | AMPK activator, motor function improver, muscle endurance improver and muscle atrophy inhibitor |
WO2023068209A1 (en) * | 2021-10-19 | 2023-04-27 | 丸善製薬株式会社 | Ampk activator, motor function improving agent, muscular endurance improving agent, and muscle atrophy preventing agent |
JP2023061133A (en) * | 2021-10-19 | 2023-05-01 | 丸善製薬株式会社 | Ampk activator, motor function improving agent, muscular endurance improving agent, and muscle atrophy preventing agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5985138B2 (en) | Energy consumption promoter | |
JP5714227B2 (en) | Anti-fatigue agent and oral composition containing andrographolide as active ingredient | |
Fern et al. | Effects of exaggerated amino acid and protein supply in man | |
US5888553A (en) | Non-steroidal anabolic composition | |
Malinow et al. | Alfalfa seeds: effects on cholesterol metabolism | |
Yonei et al. | Effects on the human body of a dietary supplement containing L-carnitine and Garcinia cambogia extract: a study using double-blind tests | |
EP2050444A1 (en) | Fatigue-reducing agent | |
US6608109B2 (en) | Composition comprising L-arginine as a muscle growth stimulant and use thereof | |
KR20120097516A (en) | Hyperlipemia-ameliorating agent, anemia-ameliorating composition, uric-acid-level-reducing composition, and foods and beverages | |
Benevenga et al. | Effect of an amino acid imbalance on the metabolism of the most-limiting amino acid in the rat | |
CN106668507A (en) | Medicine for curing male infertility and preparation method thereof | |
ES2747932T3 (en) | Use of phytoecdisonas in the preparation of a composition to act on the metabolic syndrome | |
JP2001161314A (en) | Motor ability enhancer based on ferulic acid salt | |
JP4397663B2 (en) | Muscle mass increasing agent | |
SUZUKI et al. | Effects of carnitine administration, fasting, and exercise on urinary carnitine excretion in man | |
CN102273581A (en) | Compound sweetener with high sweetness | |
JP7137483B2 (en) | Ammonia metabolism accelerator | |
JPWO2007077995A1 (en) | Muscle bulking agent | |
Oldfield | Some implications of selenium for human health | |
JP6677775B2 (en) | Muscle builders | |
TW200812569A (en) | Bone density increasing agent | |
JP4122121B2 (en) | Fat metabolism promoter and food and drink containing the same | |
JP7108610B2 (en) | Ammonia metabolism accelerator | |
JP2023160181A (en) | Agent for increasing level of ornithine in blood | |
US20050043287A1 (en) | Composition comprising L-arginine as a muscle growth stimulant and use thereof |